Today's discussion on unraveling BPC 157 Peptide
by Infinity Peptides
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·69 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 17 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Dihexa: Rewiring the Brain
Jul 20, 2026
21m 39s
ARA-290: The Science of Regenerative Nerve Repair
Jul 15, 2026
21m 44s
GHK-Cu: The Science of the Copper Peptide
Jun 22, 2026
19m 56s
NAD+ and Epitalon: The Longevity Stack
Jun 15, 2026
21m 35s
The secret Hollywood stack
Jun 5, 2026
23m 16s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | synthetic peptidesbiohacking+4 | — | DihexaHGF/c-Met+1 | — | Dihexasynthetic peptide+6 | — | 21m 39s | ||
| 7/15/26 | nerve repairpeptides+3 | — | ARA-290erythropoietin+2 | — | ARA-290nerve regeneration+5 | — | 21m 44s | ||
| 6/22/26 | copper peptideregenerative pathways+5 | — | GHK-Cucopper peptide+1 | — | GHK-Cucopper peptide+5 | — | 19m 56s | ||
| 6/15/26 | biohackinglongevity+5 | — | NAD+Epitalon+2 | — | NAD+Epitalon+5 | — | 21m 35s | ||
| 6/5/26 | growth hormone secretagoguesCJC-1295+4 | — | CJC-1295Ipamorelin+1 | — | CJC-1295Ipamorelin+5 | — | 23m 16s | ||
| 5/29/26 | peptidesanxiolytic properties+3 | — | Selanktuftsin+1 | Russia | Selankpeptide+5 | — | 18m 54s | ||
| 5/25/26 | peptidesmetabolic health+5 | — | BPC 157 PeptideMOTS-c+1 | — | MOTS-cpeptide+6 | — | 19m 04s | ||
| 3/9/26 | mitochondriahealth+3 | — | BPC 157 PeptideSS-31+1 | — | mitochondrial medicineSS-31+4 | — | 19m 37s | ||
| 2/12/26 | peptidesscience+5 | — | BPC 157 PeptideSnap-8+2 | — | Snap-8BPC 157+4 | — | 14m 26s | ||
| 2/2/26 | BPC 157peptides+3 | — | BPC 157 PeptideInfinity Peptides | — | BPC 157peptide+4 | — | 16m 39s | ||
| 1/26/26 | weight managementneurochemicals+3 | — | Tesofensinedementia possibility drug+1 | — | Tesofensineweight management+3 | — | 15m 04s | ||
| 1/20/26 | TB500peptides+3 | — | TB500BPC 157 Peptide | — | TB500peptides+3 | — | 17m 01s | ||
| 1/12/26 | immune modulationThymosin Alpha-1+3 | — | Thymosin Alpha-1Infinity Peptides | — | Thymosin Alpha-1immune mechanisms+3 | — | 38m 17s | ||
| 1/5/26 | clinical researchpeptide science+5 | — | TesamorelinIGF-1+2 | — | TesamorelinFDA approval+7 | — | 11m 58s | ||
| 12/29/25 | clinical researchpeptide science+5 | — | BPC 157 PeptideCJC1295+4 | — | BPC 157CJC1295+8 | — | 12m 30s | ||
| 12/22/25 | MOTS-c peptidemitochondrial health+4 | — | MOTS-c peptideInfinity Peptides | — | MOTS-cmitochondrial DNA+6 | — | 33m 07s | ||
| 12/15/25 | hCG peptidehormone optimization+5 | — | hCGInfinity Peptides | — | hCGpeptide+8 | — | 13m 09s |
Showing 17 of 17
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.